Evoke (EVOK) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
12 Aug, 2026Executive summary
Resilient underlying performance with stable group revenue at £887.5m–£888m, up 2% like-for-like, despite significant increases in gaming duties, especially in the UK.
Adjusted EBITDA declined 9.5%–10% year-over-year to £150.2m, mainly due to a £46m rise in gaming duties, partially offset by operational efficiencies.
UK & I Online delivered strong profitable growth, with revenue up 3.5%–4% and Adjusted EBITDA up 28%–28.3%, driven by William Hill gaming and mitigation actions.
Retail profitability improved, with like-for-like revenue up 4% and Adjusted EBITDA up 5%–5.4% following the closure of approximately 200–270 shops.
International segment showed strong growth in Italy (+21%) and Denmark (+13%), but declines in Spain, Romania, and other regions, with higher duty costs impacting results.
Financial highlights
Group revenue stable at £887.5m (H1 2026) vs £887.8m (H1 2025); like-for-like revenue up 2%.
Adjusted EBITDA at £150.2m, down 9.5%–10% year-over-year, reflecting higher gaming duties.
Reported EBITDA fell 12% to £124.8m, reflecting higher exceptional costs.
Net loss after tax was £70.2m, broadly unchanged from H1 2025.
Adjusted net profit after tax was £1.9m, up from nil in H1 2025.
Outlook and guidance
Recommended acquisition by Bally's Intralot progressing as planned, with completion expected in Q4 2026 or Q1 2027, subject to approvals.
Continued focus on operational momentum, cash generation, and disciplined execution during the acquisition process.
Trading since period end has remained in line with expectations, with strong customer engagement during the FIFA World Cup.
No forward-looking financial guidance provided due to the pending acquisition.
Latest events from Evoke
- H2 revenue growth of 5-9% and margin recovery expected, driven by cost savings and innovation.EVOK
Trading Update8 Jul 2026 - AGM focused on acquisition plans, improved 2025 results, and responses to UK regulatory changes.EVOK
AGM 20268 Jun 2026 - Revenue and EBITDA rose, margins improved, and leverage fell amid strategic review and UK duty headwinds.EVOK
H2 202530 Apr 2026 - Revenue down, losses widen, but transformation and H2 margin recovery on track.EVOK
H1 20241 Feb 2026 - FY25 revenue up 2%, EBITDA up 14-15%, with a strategic review amid UK tax hikes.EVOK
Q4 2025 TU27 Jan 2026 - Growth resumed in 2024 with rising margins, strong core markets, and a clear deleveraging plan.EVOK
H2 202426 Dec 2025 - Business transformation, renewed growth, and enhanced governance were key AGM themes.EVOK
AGM 202527 Nov 2025 - Strong revenue and EBITDA growth, improved margins, and significant deleveraging achieved.EVOK
H1 202523 Nov 2025 - Revenue up 5% in Q3 2025, all divisions grew, and FY25 EBITDA margin guidance reaffirmed.EVOK
Q3 2025 TU28 Oct 2025